Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Return on Assets [ROA] (2011 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) reported Return on Assets [ROA] of -25.81% for Q2 2026, up 2.21 percentage points from -28.02% a year earlier but down 1.35 percentage points from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Madrigal Pharmaceuticals posted Return on Assets [ROA] of -24.77%, up 30.60 percentage points from FY2024.

  • Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +30.74 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -55.37% in FY2024 (+19.12 pp), -74.49% in FY2023 (+18.40 pp), -92.89% in FY2022 (-6.47 pp) and -86.42% in FY2021 (-30.91 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -146.12% in Q3 2022 and a high of -21.74% in Q4 2025.
  • Year over year, Return on Assets [ROA] has now increased in each of the last 14 quarters, with an average year-over-year change of +26.99 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q3 2024 (a gain of 80.81 percentage points); the low point was Q3 2022 (a drop of 71.29 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -24.46% (Q1 2026), -21.74% (Q4 2025) and -24.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn - -25.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.81%
Mar 31, 2026 -24.46%
Dec 31, 2025 -21.74%
Sep 30, 2025 -24.06%
Jun 30, 2025 -28.02%
Mar 31, 2025 -38.41%
Dec 31, 2024 -44.05%
Sep 30, 2024 -47.74%
Jun 30, 2024 -46.79%
Mar 31, 2024 -51.58%
Dec 31, 2023 -85.06%
Sep 30, 2023 -128.54%
Jun 30, 2023 -103.89%
Mar 31, 2023 -90.57%
Dec 31, 2022 -113.33%
Sep 30, 2022 -146.12%
Jun 30, 2022 -116.57%
Mar 31, 2022 -99.52%
Dec 31, 2021 -83.77%
Sep 30, 2021 -74.83%
API Access

Madrigal Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MDGL&period=max&api_key=YOUR_API_KEY